EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma

Songmao Li, Yuhan Zhang, Yueqing Han, Min Zhao, Yi Wang, Jinying Lu, Ran Li, RuiYu Wang, Ruimin Shan, Wenhua You, Hulin Jiang, Judong Luo und 2 weitere

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7589-7613

DOI: 10.1016/j.apsb.2026.05.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Songmao Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu,…. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Provincial Key Research and Development Program, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Biomimetic carriersCancer immunotherapyReprogrammingSTINGTumor microenvironmentTumor-associated neutrophils (TAN)mRNA therapeuticsmRNA vaccines

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China; Nanjing Medical Key Laboratory of Laryngopharynx-Head & Neck O…
  • Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing 211166, China.
  • Department of Immunology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer…
  • National Vaccine Innovation Platform, Nanjing Medical University, Nanjing 211166, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
  • Department of Radiotherapy, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Förderung

  • Jiangsu Provincial Key Research and Development Program
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Nanjing Medical University
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Li, S., Zhang, Y., Han, Y., Zhao, M., Wang, Y., Lu, J., Li, R., Wang, R., Shan, R., You, W., Jiang, H., Luo, J., Hu, C., & Chen, Y. (2026). Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma. Acta Pharmaceutica Sinica B, 16(11), 7589-7613. https://doi.org/10.1016/j.apsb.2026.05.002

Vancouver

Li S, Zhang Y, Han Y, Zhao M, Wang Y, Lu J, et al. Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma. Acta Pharmaceutica Sinica B. 2026;16(11):7589-7613. doi:10.1016/j.apsb.2026.05.002

BibTeX
@article{Li2026,
  author = {Li, Songmao and Zhang, Yuhan and Han, Yueqing and Zhao, Min and Wang, Yi and Lu, Jinying and Li, Ran and Wang, RuiYu and Shan, Ruimin and You, Wenhua and Jiang, Hulin and Luo, Judong and Hu, Chupeng and Chen, Yun},
  title = {Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7589--7613},
  doi = {10.1016/j.apsb.2026.05.002}
}
Kostenlos starten →